Literature DB >> 20051014

Pseudopolyneuritic form of ALS revisited: clinical and pathological heterogeneity.

Zen Kobayashi1, Kuniaki Tsuchiya, Tetsuaki Arai, Osamu Yokota, Sadakiyo Watabiki, Hideki Ishizu, Haruhiko Akiyama, Hidehiro Mizusawa.   

Abstract

Pseudopolyneuritic form of ALS is a subtype of ALS characterized by distal weakness of the unilateral lower limb and absence of Achilles tendon reflex (ATR) at disease onset. Recognition of this form of ALS is important for clinicians because the combination of distal weakness of the lower limb and absence of ATR usually suggests peripheral neuropathy. We reviewed the clinical records of 42 autopsy-proven sporadic ALS cases and found three cases that showed onset of weakness of the unilateral lower limb with distal dominance and absence of ATR. The disease duration in the three cases was 2, 3 and 19 years, respectively. The clinical features of the patient with a course of 19 years had been restricted to lower motor neuron signs. Histopathologically, consistent findings in the three cases were severe motor neuron loss throughout the whole spinal cord, with relative preservation of the hypoglossal nucleus. Reflecting this finding, TDP-43-positive neuronal cytoplasmic inclusions in the spinal cord were sparse in two cases, and absent in a third. In the patient showing a clinical course of 19 years, mild corticospinal tract degeneration appeared to correspond to the absence of upper motor neuron signs and prolonged disease duration. In this case only, Bunina bodies were not demonstrated. In this study, we clarified the clinical and pathological heterogeneity of this form of ALS.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20051014     DOI: 10.1111/j.1440-1789.2009.01084.x

Source DB:  PubMed          Journal:  Neuropathology        ISSN: 0919-6544            Impact factor:   1.906


  3 in total

Review 1.  The phenotypic variability of amyotrophic lateral sclerosis.

Authors:  Bart Swinnen; Wim Robberecht
Journal:  Nat Rev Neurol       Date:  2014-10-14       Impact factor: 42.937

Review 2.  Challenges in the Understanding and Treatment of Amyotrophic Lateral Sclerosis/Motor Neuron Disease.

Authors:  Jeffrey Rosenfeld; Michael J Strong
Journal:  Neurotherapeutics       Date:  2015-04       Impact factor: 7.620

3.  Amyotrophic lateral sclerosis in Sardinia, insular Italy, 1995-2009.

Authors:  Maura Pugliatti; Leslie D Parish; Paola Cossu; Stefania Leoni; Anna Ticca; M Valeria Saddi; Enzo Ortu; Sebastiano Traccis; Giuseppe Borghero; Roberta Puddu; Adriano Chiò; Pietro Pirina
Journal:  J Neurol       Date:  2012-09-30       Impact factor: 4.849

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.